HEALTH — Nightingale Health Oyj Income Statement
0.000.00%
Last trade - 00:00- €173.76m
- €110.36m
- €4.36m
Annual income statement for Nightingale Health Oyj, fiscal year end - June 30th, EUR millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.78 | 2.31 | 2.31 | 4.18 | 4.36 |
| Cost of Revenue | |||||
| Gross Profit | 1.77 | 2.01 | 1.35 | 3.59 | 2.91 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.12 | 12.1 | 15.9 | 22.7 | 22.9 |
| Operating Profit | -3.34 | -9.75 | -13.6 | -18.5 | -18.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.73 | -9.72 | -16.2 | -18.1 | -17.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.73 | -9.72 | -16.1 | -18.1 | -17.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.73 | -9.72 | -16.1 | -18.1 | -17.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.73 | -9.72 | -16.1 | -18.1 | -17.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.059 | -0.161 | -0.267 | -0.3 | -0.289 |
| Dividends per Share |